The Clincal Version of the Cavitat Generation 5 Ultrasonograph imaging system. (CAV40000-1)

Cavitat Medical Technologies, Inc is in the business of Developing, Manufacturing and Marketing new and innovative technologies to detect and precisely image necrosis of the bone. Used as an aid to medical professionals to diagnose the debilitating effects of Bone Marrow Edema Syndrome, Neuralgia Inducing Cavitational Osteonecrosis (NICO), Osteomyelitis, and Periodontal Pockets of the Buccal Bone.

The Cavitat Generation 5 precisely images and identifies Osteonecrosis and Osteomyelitis of the jawbone.

Cavitat Medical Technologies' Generation 5, is the world's only bone sonography imaging system.

The Cavitat Generation 5 TTAS was approved by the Canadian FDA on May 7, 2002 and granted:

* Licence Number 37968  *See Note*

* ID Number 416042

*Note: In 2004 Cavitat chose not to renew its licence to sell in Canada

The Cavitat CAV40000-1 was cleared by the United States FDA for commercial distribution on February 15, 2002.

(Reference Number K011147)

The Cavitat Generation 5 International Model uses the International Tooth Code. International Model exhibits specific bone pathology

CAVITAT MEDICAL TECHNOLOGIES, Inc.

Evidenced based Imaging